Answers are grounded in this paper and cite their sources.
Novel C-H alkenylation achieves selective synthesis of C5- or ortho-alkenylated products, indicating diverse applications.
We have developed a novel and efficient Pd(II)- and Ru(II)-catalyzed switchable C-H alkenylation of 2-arylthiazoles with alkenes, achieving high levels of regio- and stereoselectivity. This protocol enables the selective synthesis of either C5- or ortho-alkenylated products, depending on the choice of metal catalyst. The reactions involve two distinct pathways: ortho-alkenylation proceeds via chelation-assisted ruthenation, while C5-alkenylation occurs through electrophilic palladation. This regiodivergent strategy offers a versatile approach for the direct construction of π-extended 2-arylthiazole derivatives, which show promising potential for applications in medicinal chemistry and materials science.
No takes yet. Share an insight, caveat, or question.
Wan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: